You're reading the free version. Trader adds the live tape and alerts.
Start tracking
GLUE Sale Disclosure
Champoux Jennifer · SEC Form 4 · Filed Jun 25, 2026
Sale
Calculated transaction value
$43.5K
Champoux Jennifer Chief Operating Officer
GLUE
Transaction date
Jun 23, 2026
Public filing date
Jun 25, 2026
Filing lag
Filed 2 days later
GLUE daily price context
Close on/before transaction
$20.71
Jun 23, 2026
First close after public filing
$22.29
Jun 26, 2026
30-day return after filing
+1.21%
Through Jul 27, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2,175 shares @ $20
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-282735
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$52.16K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Monte Rosa Therapeutics, Inc. GLUE | Exercise | Jun 23, 2026 | $8.66K |
| Monte Rosa Therapeutics, Inc. GLUE Current | Sale | Jun 23, 2026 | $43.5K |
| Monte Rosa Therapeutics, Inc. GLUE | Exercise | Jun 23, 2026 | $0 |